WEEI/NESN Jimmy Fund Radio-Telethon

WEEI/NESN Jimmy Fund Radio-Telethon

By AudacySports
Download on the App Store

WEEI/NESN Jimmy Fund Radio-Telethon episodes

  • OMF - Madison Paskell, 16, Type B-cell acute lymphoblastic leukemia, East Bridgewater with Dr. Andrew Place, Associate Director of Developmental Therapeutics, Pediatric Hematologic Malignancy Program, Dana-Farber 8-21-18
    In March, Madison had repetitive sinus and ear infections and long-term abdominal pain. Her pediatrician decided to conduct blood work and found abnormal results. Further tests and procedures confirmed that Madison had leukemia.
    Her treatment has consisted of many different rounds of chemotherapy, steroids, bone marrow biopsies, and lumbar punctures.
    Madison's family includes her mother, Julie, 38, father, Chris, 39, and sister, Kennedy, 6.
    Madison is a rising junior at East Bridgewater Junior Senior High School. In her spare time, she loves hanging out with her friends and family.
    Her favorite part of the Jimmy Fund Clinic is hanging out with the nurses. She also loves Dr. Place for his sense of humor throughout her treatment.
    Dr. Place specializes in the treatment of childhood leukemia and lymphoma.  Dr. Place is also a clinical investigator studying novel targeted therapies in relapsed acute leukemia.
    He is a nationally recognized clinical trialist in pediatric oncology and serves on leadership committees of several large consortia including the Dana-Farber Cancer Institute ALL Consortium, the Therapeutic Advances in Childhood Leukemia Consortium and the Children’s Oncology Group. 
    Dr. Place is also the Chief Medical Officer of the Institutional Centers for Clinical and Translational Research at Boston Children’s Hospital. 
    Dr. Place earned his MD and PhD degrees at Dartmouth College prior to completing his Pediatric Residency and Pediatric Hematology/Oncology fellowship at Boston Children’s Hospital and the Dana-Farber Cancer Institute.  Dr. Place joined the Pediatric Hematology/Oncology faculty in 2012.
    8 min
  • D&K - Carlos Perez, 48, non-small cell lung adenocarcinoma, Norwell with Dr. Geoffrey (Jeff) Oxnard, thoracic oncologist, Dana-Farber 8-21-18

    Carlos was diagnosed with non-small cell lung adenocarcinoma in April 2017 after suffering from a chronic, non-productive cough that would not go away. Doctors prescribed antibiotics to treat his cough, but nothing seemed to be working. His doctor sent him in for a chest CT, and that is when Carlos’ cancer was first detected.

    For the past year, Carlos has been on a phase 1 clinical trial of a RET kinase inhibitor, which consists of taking pills twice a day.

    Carlos spends his free time sailing, skiing, and reading books. He is supported by his wife, Shawn, and children, K, Alec, and Isabel.

    Last August, Carlos ran into a series of complications with his diagnosis that left him in the hospital for 2 weeks. Both the level of care at the hospital and the close coordination between specialists was critical to getting him back on his feet. This is part of the reason that Carlos chose Dana-Farber initially. He appreciates the scientific excellence and patient care that the Institute provides.

    Dr. Oxnard is a lung cancer expert in the Lowe Center for Thoracic Oncology at Dana-Farber

    Besides treating lung cancer patients, Dr. Oxnard spends a lot of time on research.  His current research study includes liquid biopsies. Liquid biopsies are non-invasive blood tests that detect circulating tumor cells and fragments of tumor DNA that are shed into the blood.

    7 min
  • D&K - John LaBrie, 42, HPV cancer in left tonsil and lymph node, Springfield with Dr. Glenn Hanna, Head & Neck Program, Dana-Farber 8-21-18

    John initially went to the doctor in May 2017 to treat what he thought was strep throat. Multiple doctor visits revealed a larger issue and John was diagnosed with HPV cancer of his left tonsil and lymph node region.

    After his diagnosis, John underwent rounds of chemotherapy and radiation. However, he has now completed his treatment.

    Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.

    Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.

    The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.

    John initially chose Dana-Farber for his care because of its affiliations and its reputation for excellent care in the area. 

    In his spare time, John loves to golf and run. This year, he will be running the Boston Marathon to raise money for Dana-Farber under the charity “Golf Fights Cancer.”

    Throughout his treatment, John has been supported by his wife, Cheryl, and their four kids.

    Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.

    Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.

    The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.

    7 min
  • D&K - Carlos Perez, 48, non-small cell lung adenocarcinoma, Norwell with Dr. Geoffrey (Jeff) Oxnard, thoracic oncologist, Dana-Farber 8-21-18
    Carlos was diagnosed with non-small cell lung adenocarcinoma in April 2017 after suffering from a chronic, non-productive cough that would not go away. Doctors prescribed antibiotics to treat his cough, but nothing seemed to be working. His doctor sent him in for a chest CT, and that is when Carlos’ cancer was first detected.
    For the past year, Carlos has been on a phase 1 clinical trial of a RET kinase inhibitor, which consists of taking pills twice a day.
    Carlos spends his free time sailing, skiing, and reading books. He is supported by his wife, Shawn, and children, K, Alec, and Isabel.
    Last August, Carlos ran into a series of complications with his diagnosis that left him in the hospital for 2 weeks. Both the level of care at the hospital and the close coordination between specialists was critical to getting him back on his feet. This is part of the reason that Carlos chose Dana-Farber initially. He appreciates the scientific excellence and patient care that the Institute provides.
    Dr. Oxnard is a lung cancer expert in the Lowe Center for Thoracic Oncology at Dana-Farber
    Besides treating lung cancer patients, Dr. Oxnard spends a lot of time on research.  His current research study includes liquid biopsies. Liquid biopsies are non-invasive blood tests that detect circulating tumor cells and fragments of tumor DNA that are shed into the blood.
    7 min
  • D&K - John LaBrie, 42, HPV cancer in left tonsil and lymph node, Springfield with Dr. Glenn Hanna, Head & Neck Program, Dana-Farber 8-21-18
    John initially went to the doctor in May 2017 to treat what he thought was strep throat. Multiple doctor visits revealed a larger issue and John was diagnosed with HPV cancer of his left tonsil and lymph node region.
    After his diagnosis, John underwent rounds of chemotherapy and radiation. However, he has now completed his treatment.
    Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.
    Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.
    The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.
    John initially chose Dana-Farber for his care because of its affiliations and its reputation for excellent care in the area. 
    In his spare time, John loves to golf and run. This year, he will be running the Boston Marathon to raise money for Dana-Farber under the charity “Golf Fights Cancer.”
    Throughout his treatment, John has been supported by his wife, Cheryl, and their four kids.
    Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.
    Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.
    The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.
    7 min
  • D&K - Kindy Pichardo, 22, acute lymphoblastic leukemia, Lawrence with Dr. Robert Soiffer, Chief Hematologic Malignancies Program, Co-Chief Adult Stem Cell Transplantation Program, Dana- Farber 8-21-18

    In April 2017, Kindy ended up in the hospital with what doctors thought was the flu. It was not until her hospital release check-up that doctors realized that she had leukemia.

    Her treatment consisted of chemotherapy, radiation, and a bone marrow transplant. Kindy is no longer undergoing treatment, and just came up on her one-year anniversary of her marrow transplant.

    At the time of her diagnosis, Kindy was six months pregnant. Her OB-GYN recommended that she be treated at Dana-Farber.

    Kindy is an artist—she spends her time doing make-up, writing and drawing. She loves any activity that uses her creativity.

    Prior to her diagnosis, Kindy was finishing up cosmetology school. She is now enrolling in classes to study entertainment business and management.

    Dr. Soiffer is world-renowned in the field of bone marrow and stem cell transplant procedures.

    Throughout her treatment, Kindy has been supported by her daughter, mother, step-mother, sister, aunts, uncles, cousins, and grandmothers.

    8 min

About WEEI/NESN Jimmy Fund Radio-Telethon

From the publisher's feed

Hear stories of hope and inspiration for a cancer-free future from the annual WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance.